Persistence of mutations during remission in 114 AML patients.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ČULEN Martin HERUDKOVÁ Zdeňka JEŽÍŠKOVÁ Ivana FOLTA Adam TOM Nikola VENGLÁŘ Ondřej DVOŘÁKOVÁ Dana MAYER Jiří RÁČIL Zdeněk

Year of publication 2018
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description The current prognostic stratification of acute myeloid leukemia (AML) patients recognizes several recurrently mutated genes in AML as prognostic markers at the time of diagnosis. However, previous studies indicate that additional prognostic information can be further obtained by detection of pre-leukemic mutations that persist in clinical remission and represent clonal hematopoiesis.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.